Artelo Biosciences initially below $5M Nasdaq threshold

(Moderate)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Artelo Biosciences (ARTL) reported that Nasdaq’s new rule requires listed companies to maintain a market value of listed securities of at least $5,000,000; companies below the threshold may face delisting proceedings unless they demonstrate a plan to regain compliance within a specified period. The SEC approved the rule on July 22, 2026, and a temporary stay was announced on July 29, 2026. On October 5, 2026, the SEC published notice of Nasdaq’s proposal to make the rule operative when the stay ends; comments are due October 29, 2026.

If the rule takes effect in a form that applies to Artelo, the company expects to consider possible compliance steps. These could include raising capital through its existing at-the-market equity offering program or other equity or equity-linked financings, actions involving outstanding warrants or other securities, advancing development programs, and managing operating expenses. Artelo has not committed to a particular course of action.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance works How Sentiment works

1 major · 1 point

How the balance works

Positive

None.

Negative

Major pointArtelo was initially identified below Nasdaq’s $5,000,000 MVLS threshold.

Filing Explained

Nasdaq initially identified Artelo among companies below the $5 million market-value threshold; the rule is under a temporary stay, and the filing says the stay’s duration and the rule’s final form remain unknown.

8-K Event Classification

Item 8.01 — Other Events

1 item

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Key Figures

MVLS minimum: $5,000,000 Companies initially identified below threshold: Approximately 180 companies SEC approval date: July 22, 2026 +1 more

4 metrics

MVLS minimum $5,000,000 Nasdaq listing rule threshold

Companies initially identified below threshold Approximately 180 companies Nasdaq-listed companies, including Artelo

SEC approval date July 22, 2026 Approval of Nasdaq’s new listing compliance rule

Comments due October 29, 2026 Nasdaq proposal to modify the rule’s operative date

Key Terms

market value of listed securities, temporary stay, at-the-market equity offering program

3 terms

market value of listed securities regulatory

"market value of listed securities (“MVLS”)"

Market value of listed securities is the market value of the shares a company has listed on an exchange, calculated as the closing bid price multiplied by the number of listed shares. Exchanges use it as a continued-listing standard, so a company that stays under the required minimum receives a deficiency notice and is given a set period to recover before facing delisting.

temporary stay regulatory

"a temporary stay of the $5M MVLS Rule was announced"

at-the-market equity offering program financial

"the Company’s existing at-the-market equity offering program"

A program that lets a company sell newly issued shares directly into the open market at whatever the current trading price is, usually through a broker, and do so gradually over time instead of all at once. Investors care because it can dilute existing ownership and put steady selling pressure on the stock price, while giving the company a flexible, on-demand way to raise cash — like adding small amounts of water to a pool rather than dumping in a bucket.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the Nasdaq $5 million rule and how could it affect ARTL?

It requires Nasdaq-listed companies to maintain a market value of listed securities of at least $5,000,000; companies below that threshold may face delisting proceedings unless they demonstrate a plan to regain compliance within a specified period. Artelo was among approximately 180 companies initially identified below the threshold.

When could the Nasdaq $5 million rule take effect for ARTL?

Nasdaq proposed that the rule’s operative date be upon termination of the temporary stay. The SEC published notice of the proposed change on October 5, 2026; comments are due October 29, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/09/2026 - 05:16 PM EDT Accepted by SEC EDGAR 10/09/2026 - 05:15 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 9, 2026

ARTELO BIOSCIENCES, INC.

(Exact name of Company as specified in its charter)

Nevada

001-38951

33-1220924

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

505 Lomas Santa Fe, Suite 160

Solana Beach, CA USA

92075

(Address of principal executive offices)

(Zip Code)

(858) 925-7049

(Company’s telephone number, including area code)

___________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		ARTL		The Nasdaq Stock Market LLC

Indicate by check mark whether the Company is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the Company has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On July 22, 2026, the Securities and Exchange Commission (the “SEC”) approved The Nasdaq Stock Market LLC’s (“Nasdaq”) new listing compliance rule that requires listed companies to maintain a market value of listed securities (“MVLS”) of at least $5,000,000 (the “$5M MVLS Rule”). Companies that fall below this threshold may be subject to delisting proceedings unless they can demonstrate a plan to regain compliance within a specified period.

Approximately 180 companies listed on Nasdaq were initially identified as having an MVLS below the new threshold, including Artelo Biosciences, Inc. (the “Company”). On July 29, 2026, a temporary stay of the $5M MVLS Rule was announced. On October 5, 2026, the SEC published a notice from Nasdaq for a proposed rule change to modify the operative date of the $5M MVLS Rule to be upon termination of the temporary stay. Comments on the proposed rule change are due by October 29, 2026. As of the date of this filing, the Company has no information regarding how long the stay will remain in effect, whether the $5M MVLS Rule will be reinstated in its current form, or whether any modifications to the rule will be adopted.

The Company intends to monitor developments relating to the $5M MVLS Rule and, if the rule takes effect in a form that applies to the Company, expects to consider the steps available to it to regain or maintain compliance. Depending on the final form of the rule and the circumstances at the time, those steps could include, among other things, raising capital through the Company’s existing at-the-market equity offering program or other equity or equity-linked financings, actions with respect to outstanding warrants or other securities, continued advancement of the Company’s development programs, management of operating expenses, and other corporate actions. The Company has not committed to any particular course of action, is not soliciting proposals for any transaction, and does not intend to disclose further developments unless and until it determines that disclosure is appropriate or required. There can be no assurance that the Company will take any particular action, that any particular transaction or strategy will be completed or that any such action will result in the Company achieving or maintaining compliance with the $5M MVLS Rule.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 9, 2026	ARTELO BIOSCIENCES, INC.

	/s/ Gregory D. Gorgas
	Name:	Gregory D. Gorgas
	Title:	Chief Executive Officer and President

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents